Obesity, Cardiac Health, And Bupropion-Naltrexone

Embed Size (px)

Citation preview

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    1/41

    Obesity,CardiacHealth, and

    Bupropion/Naltrexone THE DREAM AND THEN !HTMARE

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    2/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    3/41

    Obesity

    One"third o# the $% population is obese▪ One"third o# the $% population is o&er'ei(ht▪ Associated 'ith a plethora o# )edical co)plications

    ▪ T*DM▪ C+D▪ HTN▪ Depression▪ CAD▪ %tro e▪ %o)e cancers

    American Journal of Preventive Medicine

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    4/41

    Obesity

    Obesity"related )orbidity leads to increasedhospitali-ation and (reater )ortality▪ %econd to s)o in( as the leadin( cause o# pre&entable

    death▪ Esti)ated )edical costs o# obesity . 011 billion per

    annu)▪ 2e' dru(s a&ailable due to e3cacy and sa#ety concerns

    ▪ 2en"phen

    ▪ 45i#estyle )odi6cation has lon( been considered a)ainstay o# therapy #or obesity, but his inter&ention has

    produced only )odest 'ei(ht loss and no reduction in)a7or ad&erse cardio&ascular e&ents 8MACE9:; 8 JAM

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    5/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    6/41

    Obesity

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    7/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    8/41

    T'o Dru(s

    Bupropion 8B$

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    9/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    10/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    11/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    12/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    13/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    14/41

    Conclusion

    B$< @ NA5 co)bination treat)ent 'or ed in syner(y toreduce #ood inta e▪ E=ect li ely due to increased

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    15/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    16/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    17/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    18/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    19/41

    Conclusions

    B$< @ NA5 coad)inistration leads to a 'ei(ht"reducin(anorectic e=ect▪ 5on(er ter) studies needed to sho' di&er(ence

    bet'een B$< @ NA5 and B$< @ <▪

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    20/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    21/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    22/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    23/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    24/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    25/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    26/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    27/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    28/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    29/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    30/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    31/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    32/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    33/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    34/41

    Conclusions

    ▪ t is not possible to assess nonin#eriority due to earlytrial ter)ination

    ▪ 4Cardio&ascular sa#ety o# this treat)ent re)ainsuncertain and 'ill re uire e&aluation in a ne'ade uately po'ered outco)e trial:;

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    35/41

    My conclusion

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    36/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    37/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    38/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    39/41

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    40/41

    Clic icon to add picture

  • 8/15/2019 Obesity, Cardiac Health, And Bupropion-Naltrexone

    41/41